Supplementation of α-tocopherol improves cardiovascular risk factors via the insulin signalling pathway and reduction of mitochondrial reactive oxygen species in type II diabetic rats

References

• Endemann DH, Schiffrin EL. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus. Curr Hypertens Rep 2004; 6: 85–89
   PubMed Web of Science ®Google Scholar
• Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405–412
   PubMed Web of Science ®Google Scholar
• Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1–9
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813–820
   PubMed Web of Science ®Google Scholar
• Zou Y, Jung KJ, Kim JW, Yu BP, Chung HY. Alteration of soluble adhesion molecules during aging and their modulation by calorie restriction. Faseb J 2004; 18: 320–322
   PubMed Web of Science ®Google Scholar
• Minamiyama Y, Bito Y, Takemura S, Takahashi Y, Kodai S, Mizuguchi S, Nishikawa Y, Suehiro S, Okada S. Calorie restriction improves cardiovascular risk factors via reduction of mitochondrial reactive oxygen species in type II diabetic rats. J Pharmacol Exp Ther 2007; 320: 535–543
   PubMedGoogle Scholar
• Takino T, Yasui H, Yoshitake A, Hamajima Y, Matsushita R, Takada J, Sakurai H. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis. J Biol Inorg Chem 2001; 6: 133–142
   PubMed Web of Science ®Google Scholar
• Hensley K, Benaksas EJ, Bolli R, Comp P, Grammas P, Hamdheydari L, Mou S, Pye QN, Stoddard MF, Wallis G, Williamson KS, West M, Wechter WJ, Floyd RA. New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine. Free Radic Biol Med 2004; 36: 1–15
   PubMed Web of Science ®Google Scholar
• Pryor WA, Stahl W, Rock CL. Beta carotene: from biochemistry to clinical trials. Nutr Rev 2000; 58: 39–53
   PubMed Web of Science ®Google Scholar
• Heinecke JW. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler Thromb Vasc Biol 2001; 21: 1261–1264
   PubMed Web of Science ®Google Scholar
• Ricciarelli R, Zingg JM, Azzi A. Vitamin E 80th anniversary: a double life, not only fighting radicals. IUBMB Life 2001; 52: 71–76
   PubMedGoogle Scholar
• Brigelius-Flohe R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, Azzi A. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 2002; 76: 703–716
   PubMed Web of Science ®Google Scholar
• Leonard SW, Paterson E, Atkinson JK, Ramakrishnan R, Cross CE, Traber MG. Studies in humans using deuterium-labeled alpha- and gamma-tocopherols demonstrate faster plasma gamma-tocopherol disappearance and greater gamma-metabolite production. Free Radic Biol Med 2005; 38: 857–866
   PubMed Web of Science ®Google Scholar
• Wagner KH, Kamal-Eldin A, Elmadfa I. Gamma-tocopherol—an underestimated vitamin?. Ann Nutr Metab 2004; 48: 169–188
   PubMed Web of Science ®Google Scholar
• Jiang Q, Ames BN. Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. Faseb J 2003; 17: 816–822
   PubMed Web of Science ®Google Scholar
• Takahashi K, Komaru T, Takeda S, Takeda M, Koshida R, Nakayama M, Kokusho Y, Kawakami Y, Yamaguchi N, Miyazawa T, Shimokawa H, Shirato K. gamma-tocopherol, but not alpha-tocopherol, potently inhibits neointimal formation induced by vascular injury in insulin resistant rats. J Mol Cell Cardiol 2006; 41: 544–554
   PubMedGoogle Scholar
• Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000; 26: 163–176
   PubMed Web of Science ®Google Scholar
• Davi G, Falco A, Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal 2005; 7: 256–268
   PubMed Web of Science ®Google Scholar
• Hayden MR, Tyagi SC. Myocardial redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and congestive heart failure. Med Sci Monit 2003; 9: SR35–SR52
   PubMedGoogle Scholar
• Johnson PR, Dolman NJ, Pope M, Vaillant C, Petersen OH, Tepikin AV, Erdemli G. Non-uniform distribution of mitochondria in pancreatic acinar cells. Cell Tissue Res 2003; 313: 37–45
   PubMedGoogle Scholar
• Presley AD, Fuller KM, Arriaga EA. MitoTracker Green labeling of mitochondrial proteins and their subsequent analysis by capillary electrophoresis with laser-induced fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 793: 141–150
   PubMed Web of Science ®Google Scholar
• Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids. Ann NY Acad Sci 1992; 669: 7–20
   PubMed Web of Science ®Google Scholar
• Christen S, Woodall AA, Shigenaga MK, Southwell-Keely PT, Duncan MW, Ames BN. gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci USA 1997; 94: 3217–3222
   PubMed Web of Science ®Google Scholar
• Wu JH, Hodgson JM, Ward NC, Clarke MW, Puddey IB, Croft KD. Nitration of gamma-tocopherol prevents its oxidative metabolism by HepG2 cells. Free Radic Biol Med 2005; 39: 483–494
   PubMed Web of Science ®Google Scholar
• Appenroth D, Karge E, Kiessling G, Wechter WJ, Winnefeld K, Fleck C. LLU-alpha, an endogenous metabolite of gamma-tocopherol, is more effective against metal nephrotoxicity in rats than gamma-tocopherol. Toxicol Lett 2001; 122: 255–265
   PubMed Web of Science ®Google Scholar
• Aydemir O, Naziroglu M, Celebi S, Yilmaz T, Kukner AS. Antioxidant effects of alpha-, gamma- and succinate-tocopherols in guinea pig retina during ischemia-reperfusion injury. Pathophysiology 2004; 11: 167–171
   PubMedGoogle Scholar
• Takahashi H, Kosaka N, Nakagawa S. alpha-Tocopherol protects PC12 cells from hyperoxia-induced apoptosis. J Neurosci Res 1998; 52: 184–191
   PubMedGoogle Scholar
• Kim IJ, Kim YK, Son SM, Hong KW, Kim CD. Enhanced vascular production of superoxide in OLETF rat after the onset of hyperglycemia. Diabetes Res Clin Pract 2003; 60: 11–18
   PubMedGoogle Scholar
• Heller R, Hecker M, Stahmann N, Thiele JJ, Werner-Felmayer G, Werner ER. Alpha-tocopherol amplifies phosphorylation of endothelial nitric oxide synthase at serine 1177 and its short-chain derivative trolox stabilizes tetrahydrobiopterin. Free Radic Biol Med 2004; 37: 620–631
   PubMedGoogle Scholar
• Goya K, Sumitani S, Otsuki M, Xu X, Yamamoto H, Kurebayashi S, Saito H, Kouhara H, Kasayama S. The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells. J Diabetes Complications 2006; 20: 336–342
   PubMedGoogle Scholar
• Lee KU, Lee IK, Han J, Song DK, Kim YM, Song HS, Kim HS, Lee WJ, Koh EH, Song KH, Han SM, Kim MS, Park IS, Park JY. Effects of recombinant adenovirus-mediated uncoupling protein 2 overexpression on endothelial function and apoptosis. Circ Res 2005; 96: 1200–1207
   PubMedGoogle Scholar
• Ho FM, Lin WW, Chen BC, Chao CM, Yang CR, Lin LY, Lai CC, Liu SH, Liau CS. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. Cell Signal 2006; 18: 391–399
   PubMed Web of Science ®Google Scholar